
Poisoning is the absorption of chemical, physical, or organic substances into the body by the gastrointestinal tract, skin, mucosa or respiratory tract or by injection, causing toxic effects and cell, tissue and organ damage. This is a major public health problem that causes many of the emergency admissions. Toxic exposure can be with a wide clinical picture.
Objectives: Despite the potential health risks, Paracetamol is commonly misused for management of hangover among regular users of alcohol. Studies on the combined use of the two drugs are limited and controversial. The aim of this study was to evaluate the effects of the interaction of the two drugs on the biological parameters of a rat model. Methods: Animals were divided into twelve groups. The negative and positive controls received distilled water and alcohol, respectively. Alcohol was administered at 2.5, 3.5 and 4.5 g/kg orally for 4 weeks. Paracetamol was given at doses of 40 and 400 mg/kg. Half of the other groups received combined doses of the two drugs. Hematological and blood chemistry were determined using auto-analyzers while histostructure was scored under light microscopy. Results: Alcohol induced a dose and time dependent gain on body weight, but when used in combination with paracetamol the effect was mixed. When used independently and combined, the drugs did not affect (p>0.05) the hematological profiles. For blood chemistry, the drugs caused a dose dependent elevation of liver enzymes, bilirubin, urea, reduced albumin levels and various degrees of liver and renal pathology. Conclusion: In moderate doses, Paracetamol is safe but high doses and chronic use of alcohol causes hepatotoxicity. Individually, alcohol and Paracetamol have a low risk of renal damage but when used together the risk is increased. Thus, regular use of Paracetamol in management of alcohol induced hangover is discouraged as this increases the risk of liver and kidney diseases.
There is interest in the use of nano materials as drug delivery vehicles or diagnostic systems, able to modulate cellular responses, which can be easily altered by many factors. Nanoparticles made of chitosan are considered suitable drug carriers due to their biocompatible properties; on the other hand, glutathione plays an essential role in the modulation of the redox balance into the cell. Glutathione is the major intracellular antioxidant, with many essential signaling functions. The depletion of this tripeptide activates several ways implied on the modulation of redox status that could lead to oxidative stress. Considering the activity of glutathione in various cellular events and the fact that its synthesis is only generated at the cytoplasmic level, the purpose of this work is to evaluate the ability of nanoparticles prepared with chitosan and glutathione to modulate redox cell responses on mouse liver cells (AML-12) exposed to L-Buthionine Sulfoximine (BSO) an inhibitor of the glutathione synthesis. Chitosan-glutathione nanoparticles were manufactured by ionic gelation then characterized by Transmission Electron Microscopy (TEM), Dynamic Light Scattering (DLS), and Z potential. The intracellular localization and cytotoxicity nanoparticles particles were evaluated by confocal microscopy and MTT assays, respectively. The ability to incorporate glutathione was determined through the intracellular Glutathione content assay, modulating the expression of the transcription factor Nrf2 and the antioxidant enzyme gene associated with glutathione Grx-1, was quantified using quantitative real-time PCR. The results showed nanoparticles into the cells and an increase of thiol content where nanoparticles were present, as well as an increase of the expression of Nrf2 and Grx-1 in a dose-dependent manner.